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27 Abstract:
28 Lipid mediators including classical arachidonic acid derived eicosanoids (e.g. 
29 prostaglandins and leukotrienes) and more recently identified specialized pro-
30 resolving mediator metabolites of the omega-3 fatty acids play essential roles in 
31 initiation, self-limitation and active resolution of acute inflammatory responses. In the 
32 current study, we examined the bioactive lipid mediator profile of human skeletal 
33 muscle at rest and following acute resistance exercise. Twelve male subjects 
34 completed a single bout of maximal isokinetic unilateral knee extension exercise and 
35 muscle biopsies were taken from the m.vastus lateralis before and at 2, 4 and 24 h of 
36 recovery. Muscle tissue lipid mediator profile was analysed via liquid 
37 chromatography–mass spectrometry (LC-MS)-based targeted lipidomics. At 2 h post-
38 exercise, there was an increased intramuscular abundance of cyclooxygenase (COX)-
39 derived thromboxanes (TXB2: 3.33 fold) and prostaglandins (PGE2: 2.52 fold and 
40 PGF2α: 1.77 fold). Resistance exercise also transiently increased muscle 
41 concentrations of lipoxygenase (LOX) pathway derived leukotrienes (12-Oxo LTB4: 
42 1.49 fold and 20-COOH LTB4: 2.91 fold), monohydroxy-eicosatetraenoic acids (5-
43 HETE: 2.66 fold, 12-HETE: 2.83 fold, and 15-HETE: 1.69 fold) and monohydroxy-
44 docosahexaenoic acids (4-HDoHE: 1.69 fold, 7-HDoHE: 1.58 fold and 14-HDoHE: 
45 2.35 fold). Furthermore, the abundance of CYP pathway derived epoxy- and 
46 dihydroxy-eicosatrienoic acids was increased in 2 h post-exercise biopsies (5,6-
47 EpETrE: 2.48 fold, 11,12-DiHETrE: 1.66 fold and 14,15-DiHETrE: 2.23 fold).  These 
48 data reveal a range of bioactive lipid mediators as present within human skeletal 
49 muscle tissue and demonstrate that acute resistance exercise transiently stimulates the 
50 local production of both pro-inflammatory eicosanoids and pathway markers in 
51 specialized pro-resolving mediator biosynthesis circuits.
52 Keywords: Exercise recovery, inflammation, lipids, inflammatory resolution.
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53 Introduction:
54 Skeletal muscle is a remarkably heterogeneous tissue with the capacity to 
55 adapt and respond to external stress. It is well established that intense resistance 
56 exercise can lead to improvements in muscle strength through changes in muscle fiber 
57 type, myofibrillar hypertrophy and neuromuscular mechanisms (9). However, 
58 unaccustomed exercise, especially when comprising a large eccentric component, can 
59 cause skeletal muscle injury and initiate an acute inflammatory response (1, 8, 52). 
60 Experimental models targeted at manipulating the post-exercise inflammatory 
61 response have identified that exercise-induced inflammation is a key regulatory 
62 feature in the normal process of tissue regeneration and adaptation following acute 
63 muscle damage (25, 32, 57). This suggests that molecular signaling events occurring 
64 early during acute inflammation play an active role in promoting the restoration of 
65 normal tissue function and promote skeletal muscle adaptation following an exercise 
66 stimulus.
67 The humoral and local muscular changes that occur during exercise-induced 
68 inflammation closely resemble that of an acute phase response to cellular stress. 
69 Exercise stimulus triggers the production of pro-inflammatory signaling molecules, 
70 establishing a chemotactic gradient and the diapedesis as well as potential infiltration 
71 of inflammatory leukocytes (30). These chemoattractants consist of lipid-derived 
72 mediators such as leukotrienes (LTs) and prostaglandins (PGs), as well as protein 
73 mediators, including cytokines and chemokines (40). The usual outcome of an acute 
74 inflammatory response is its successful resolution and repair of damaged tissue (47). 
75 Traditionally, the resolution of inflammation was thought to be a passive process 
76 involving the dilution and catabolism of pro-inflammatory mediators leading to the 
77 exodus of leukocytes from the site of muscle damage. However, with the discovery of 
78 novel classes of lipid-derived mediators, the resolution of acute inflammation is now 
79 seen as an active and finely controlled biochemical and metabolic process that may 
80 provide a critical link between cellular stress and tissue regeneration/adaptation (2, 
81 17). 
82 Lipid mediators are biosynthesized endogenously from essential omega-6 (n-
83 6) and omega-3 (n-3) polyunsaturated fatty acids (PUFA) and are involved in a wide 
84 range of physiological and pathophysiological processes (2). The majority of research 
85 in post-exercise inflammation has focused on classical prostaglandins (synthesized via 
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86 cyclooxygenase (COX) enzymes, COX-1 and COX-2) and leukotrienes (synthesized 
87 via the 5-lipoxygenase (5-LOX) enzyme), which are derived from the n-6 PUFA 
88 arachidonic acid (AA). These lipid mediators play a diverse role in stimulating acute 
89 inflammation by controlling local blood flow, vascular permeability, cytokine 
90 production, leucocyte chemotaxis and sensation of pain (24). On the other hand, a 
91 second class of eicosanoids also generated from AA, termed the lipoxins (LX) (20, 
92 35, 45), together with more recently identified eicosapentaenoic (EPA) (E-Series) and 
93 docosahexaenoic acid (DHA) (D-Series) derived resolvins (Rv), protectins (PD) (6, 
94 12, 38, 41, 42, 44), and maresins (MaR) (Serhan et al. 2009 & 2012) have been shown 
95 to play pro-resolution functions following acute inflammation. These novel lipid 
96 mediators, collectively termed specialized pro-resolving mediators (SPMs), act to 
97 block acute inflammatory signals by inhibiting pro-inflammatory cytokine production 
98 and subsequent neutrophil chemotaxis (36, 46). They simultaneously promote the 
99 nonphlogistic infiltration of blood monocytes/macrophages and stimulate tissue 
100 macrophages to phagocytize and clear apoptotic neutrophils whilst promoting wound 
101 healing (10, 20).
102 SPMs are formed during inflammatory transcellular interactions, involving the 
103 sequential actions of two or more cell types expressing the required LOX and/or COX 
104 enzymes in a compartmentalized manner. During the time-course of inflammation 
105 cell-cell interactions between platelets, leucocytes, the vasculature and resident tissue 
106 cells facilitates the transcellular biosynthesis of unique SPMs (23).  The temporal 
107 regulation of these lipids is therefore specific to the tissue type, inciting inflammatory 
108 stimulus (2, 17). For example, LX biosynthesis involves cellular interactions between 
109 5-LOX expressing neutrophils with 12-lipoxygenase (12-LOX) expressing platelets or 
110 15-lipoxygenase (15-LOX) expressing M2 monocytes (43). Recent findings from 
111 Markworth et al. (2013) demonstrated that SPMs, including lipoxins, resolvins and 
112 protectins, were elevated in human blood serum samples collected following an acute 
113 bout of resistance exercise (24). Peak induction of pro-inflammatory mediators 
114 including the prostaglandins and leukotrienes occurred during the early stages of post-
115 exercise muscle recovery (1-2 h), while elevated concentrations of specific SPMs 
116 were detected during both early (0-3 h: LXA4/LXB4, RvE1 and RvD1) and later (24 
117 h: PD1) stages of muscle recovery. In the present study, we used the same targeted 
118 lipidomics approach to characterize the time-course of changes in concentrations of 
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119 eicosanoid and docosanoid species locally within human skeletal muscle tissue 
120 following an acute bout of resistance exercise. We aimed to identify which species of 
121 bioactive lipid mediators are present within skeletal muscle tissue and hence may be 
122 locally generated and acting following an acute bout of resistance exercise. We 
123 hypothesized that there would be a rapid increase in pro-inflammatory prostaglandin 
124 and leukotriene biosynthesis, followed by the activation of SPM pathways at the onset 
125 of inflammatory resolution. Identification of the lipid mediator profile of skeletal 
126 muscle and ability of exercise stress to modulate intramuscular bioactive lipids will 
127 help to contribute to the understanding of a biologically active inflammatory 
128 resolution pathway that may be essential to muscle recovery and adaptation following 
129 an inflammatory event. 
130 Materials and Methods:
131 Subjects:
132 As previously described (7), fourteen untrained but recreationally active men 
133 aged 18-25 years were recruited to participate in the acute exercise study. A subset of 
134 12 male participants, for which sufficient muscle biopsy tissue remained, were 
135 included in the analysis performed here (Table 1). Exclusion criteria included 
136 participation in regular resistance exercise within one year prior to commencing the 
137 study, and/or the consumption of any nutritional or purported muscle building 
138 supplements. Each participant also completed a medical history questionnaire to 
139 identify any potential risk factors that would prevent the subjects from completing 
140 strenuous exercise. 
141 Ethics approval:
142 Each participant was provided with a written and oral explanation of the 
143 nature of the study and potential risks of the experimental procedures before 
144 providing written consent to participate. All procedures involved in the study were 
145 formally approved by the Deakin University Human Research Ethics Committee 
146 (DUHREC 2004-017) and muscle biopsy procedures were performed in order with 
147 Helsinki declaration. 
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148 Familiarization:
149 At least seven days prior to the trial day, each subject completed a 
150 familiarization session on the Cybex NORM dynamometer (Cybex International Inc. 
151 UK). The session involved performing isokinetic maximal voluntary contractions 
152 (iMVC) during concentric and eccentric knee extension exercise. Maximal force 
153 production measured as peak torque (N.m) was determined at 60°/s over 12 maximal 
154 concentric and eccentric contractions. Subjects were provided with verbal 
155 encouragement throughout the test to ensure maximal effort. 
156 Experimental design:
157 On the morning of the trial, subjects reported to the laboratory in an overnight 
158 fasted state having abstained from alcohol, caffeine and tobacco for the previous 24 h. 
159 Participants rested in a supine position for 30 min, following which a resting muscle 
160 biopsy sample was collected. Each participant then completed an acute bout of 
161 maximal concentric and eccentric isokinetic unilateral knee extension exercise on the 
162 Cybex NORM dynamometer. Subjects completed three sets of 12 maximal voluntary 
163 repetitions at a constant speed of 60°/s with 2 min of rest between each set. Subjects 
164 were instructed to contract maximally during each repetition and were provided with 
165 verbal encouragement throughout each set. Further muscle biopsy samples were 
166 obtained from the exercised leg at 2 and 4 h after completion of the exercise protocol. 
167 The following morning, subjects reported to the laboratory again in an overnight 
168 fasted state for a final follow up 24 h post-exercise muscle biopsy sample.
169 Muscle biopsy procedure:
170 Muscle biopsy samples were obtained from the m.vastus lateralis under local 
171 anaesthesia (Xylocaine 1%) using a percutaneous needle biopsy technique modified 
172 to include suction (3). A section of excised tissue was rapidly snap frozen in liquid 
173 nitrogen and stored at -80°C for further analysis. Repeat muscle biopsy samples were 
174 collected from the same leg through separate incisions separated by at least 2 cm from 
175 the previous biopsy site to minimize the risk of any localized inflammation arising 
176 from the biopsy procedure confounding exercise-induced inflammation. 
177
Au
th
or
 M
an
us
cr
ip
t
This article is protected by copyright. All rights reserved
178 Liquid chromatography-mass spectrometry (LC-MS):
179 Muscle biopsy samples were weighed and homogenized in 1 ml phosphate 
180 buffered saline (50 mM phosphate containing 0.9% sodium chloride, pH 7.4) using 
181 Zirconium beads on a high-frequency oscillator (Precellys homogenizer, Bertig 
182 Instruments). The homogenates were centrifuged at 6,000g for 10 min and the 
183 supernatant was collected for the extraction of fatty acyl lipid mediators using C18 
184 solid phase extraction cartridges as described earlier (18, 19, 24). Fatty acyl lipid 
185 mediator extracts were subjected to LC-MS analysis essentially as described before 
186 (22, 24). Under the LC-MS conditions employed, the detection limit for most of the 
187 lipid mediators was 1 pg on the column and the quantitation limit was 5 pg on the 
188 column with a signal/noise ratio >3. Tissue weights from each sample (range: 14-70 
189 mg, average: 43 mg, inter-quartile range: 32-56 mg) were used for normalization of 
190 the LC-MS data and the data are reported as ng per gram (ng/g) of tissue.
191 Statistics:
192 Statistical analysis was performed using SigmaPlot v12.3 (Systat Software 
193 Inc, Chicago, IL). Data were analyzed using a one-way repeated measures ANOVA. 
194 Following a statistically significant main ANOVA effect, Student-Newman-Keuls 
195 post hoc tests were used to determine the significance of pair-wise comparisons 
196 between individual time points. Data is presented as mean ± standard error of the 
197 mean (SEM). Statistical significance was set at P < 0.05. 
198 Results:
199 Metabolipidomic profile of human skeletal muscle tissue:
200 Lipid mediator profiles of human skeletal muscle biopsies were generated via 
201 targeted LC-MS/MS based metabolipidomics. Of the total 125 multiple reaction 
202 monitoring (MRM) transitions, 84 unique lipid mediators were reliably detected in 
203 resting skeletal muscle tissue (signal/noise ratio >3 in ≥50% of samples) 
204 (Supplemental Table 1). Detected analytes included a range n-6 and n-3 PUFA 
205 metabolites enzymatically derived from the COX, LOX and CYP pathways 
206 (Supplemental Table 1). Metabolites of linoleic acid (LA, 18:2n-6) including 
207 hydroxy-octadecadienoic acid (9-, 13-HODEs) and epoxy-octadecadienoic acids 
208 (9(10)-, 12(13)-EpOMEs) were most abundant (50-100 ng/g), followed by major 
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209 enzymatic metabolites of the n-6 PUFA AA (20:4n-6). Numerous metabolites of the 
210 n-3 PUFAs EPA (20:5n-3) and DHA (22:6n-3) were also detected at relatively lower 
211 concentrations
212 Cyclooxygenase pathways:
213 Omega-6 derived: COX enzymes catalyse the first step in the conversion of 
214 AA to prostaglandins (PGE2, PGF2ɑ, PGD2 and PGI2) and thromboxane (TXA2). 
215 TXA2 is highly unstable and non-enzymatically decomposes to TXB2 and 12(S)-
216 HHTrE. Thus, both these metabolites serve as surrogate markers of TXA2 
217 biosynthesis. TXB2 and 12(S) HHTrE were both detected within resting skeletal 
218 muscle tissue at concentrations of 1.12 ng/g and 7.68 ng/g respectively (Figure 1). At 
219 2 h post-exercise, muscle TXB2 increased to 3.73 ng/g (P = 0.002) (Figure 1A) and 
220 12(S)-HHTrE increased to 13.50 ng/g (P = 0.002) (Figure 1B). The prostaglandins 
221 PGE2 and PGF2ɑ were also detected in resting skeletal muscle tissue at concentrations 
222 of 1.13 ng/g and 0.68 ng/g respectively. At 2 h post-exercise, intramuscular PGE2 
223 increased to 2.84 ng/g (P = 0.009) (Figure 1C) and PGF2ɑ increased to 1.20 ng/g (P = 
224 0.013) (Figure 1D). Intramuscular TXB2, 12(S)HHTrE, PGE2 and PGF2α were no 
225 longer elevated above pre-exercise levels by 4 h and 24 h of recovery from the 
226 exercise bout. Other major AA derived prostaglandins including PGD2 and PGI2 
227 (measured as the stable downstream non-enzymatic metabolite 6-keto-PGF1α) were 
228 below the limit of detection of the assay used here in human muscle biopsy samples 
229 collected both before and after the resistance exercise intervention (Supplemental 
230 Table 1).
231 Omega-3 derived: The majority of series three (EPA derived) prostaglandins 
232 were below the limit of detection of our assay in human skeletal muscle tissue 
233 (Supplemental Table 1). However, a downstream bioactive metabolite of the EPA-
234 derived PGD3, 15-Deoxy-Δ12,14-prostaglandin J3, was detected at concentrations of 
235 3.09 ng/g in resting muscle. Furthermore, 15-Deoxy-Δ12,14-prostaglandin J3 increased 
236 1.35 fold to concentrations of 4.45 ng/g at 2 h post-exercise (P = 0.010) (Figure 1E). 
237 15-Deoxy-Δ12,14-prostaglandin J3 returned to basal levels by 4 h (P = 0.764) and 24 h 
238 (P = 0.344). 
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239 Lipoxygenase pathways:
240 5-LOX: The 5-LOX pathway primarily converts AA substrate to 5-
241 hydroperoxy-eicosatetranoic acid (5-HpETE), which can be reduced to 5-hydroxy-
242 eicosatetranoic acid (5-HETE), or undergo further metabolism via 5-LOX to form the 
243 leukotrienes. 5-HETE was detected in resting muscle at a concentration of 3.38 ng/g 
244 (Figure 2A). Muscle 5-HETE levels increased at 2 h post-exercise to 8.99 ng/g 
245 (p=0.017) (Figure 2A). Leukotriene B4 (LTB4) was below the level of detection of our 
246 assay in the majority of resting muscle biopsies, but was consistently detected at 
247 concentrations of ~3 ng/g at 2 h of recovery from the bout of resistance exercise 
248 (Figure 2B). Furthermore, downstream degradation products of LTB4, including 12-
249 Oxo-LTB4 and 20-COOH-LTB4 and, were both detected in resting muscle and 
250 increased in abundance at 2 h post-exercise to concentrations of 2.29 ng/g (P < 0.041) 
251 (Figure 2C) and 5.33 ng/g (P < 0.001) (Figure 2D) respectively. Intramuscular 5-LOX 
252 products of AA including 5-HETE, 12-Oxo-LTB4 and 20-COOH-LTB4 were no 
253 longer increased above basal levels at 4 h or 24 h of recovery.
254 12-LOX: The 12-LOX enzyme is expressed primarily in human platelets and 
255 metabolizes AA to form 12-hydroxy-eicosatetraenoic acid (12-HETE), which is a key 
256 stimulator of leucocyte chemotaxis and platelet aggregation (4, 59, 60). 12-HETE was 
257 by far the most abundant monohydroxylated-FA product detected in resting muscle 
258 tissue, present at concentrations of 22.51 ng/g. Muscle 12-HETE further increased 
259 above resting levels at 2 h post-exercise to concentrations of 63.81 ng/g (P = 0.01) 
260 (Figure 3A). Tetranor 12-HETE, a downstream degradation product of 12-HETE, was 
261 also detected in resting muscle tissue at lower concentrations of 0.62 ng/g and 
262 increased markedly at 2 h post-exercise to reach intramuscular concentrations of 3.97 
263 ng/g (P = 0.006) (Figure 3B). Furthermore, the 12-LOX metabolites of n-3 EPA, 12-
264 hydroxy-eicosapentaenoic acid (12-HEPE) was present in resting muscle biopsies and 
265 increased at 2 h post-exercise (P = 0.016) (Figure 3C). By 4 h and 24 h of recovery, 
266 intramuscular 12-LOX products including 12-HETE, tetranor 12-HETE and 12-HEPE 
267 no longer differed from resting levels.
268 15-LOX: The 15-LOX pathway converts AA to 15-hydroxy-eicosatetranoic 
269 acid (15-HETE) (58). 15-HETE was detected in resting muscle at 3.84 ng/g. Muscle 
270 15-HETE tended to increase at 2 h post-exercise to 6.50 ng/g, but this did not achieve 
271 statistical significance (P = 0.10) (Figure 4A). The 15-LOX metabolite of n-3 EPA, 
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272 15-hydroxy-eicosapentaenoic acid (15-HEPE) was also detected in resting muscle 
273 tissue, but was not influenced by the exercise intervention (main effect p=0.308) 
274 (Figure 4B).
275 Docosanoids: In addition to the 20-carbon PUFA AA and EPA, LOX 
276 pathway converts the 22-carbon n-3 PUFA DHA to docosanoid metabolites which 
277 most notably are key pathway markers and intermediates in the biosynthesis of the 
278 SPM family of bioactive lipid mediators.
279  The 5-LOX enzyme oxidizes n-3 DHA to form the monohydroxylated-DHA 
280 (HDoHE) products 4-hydroxy-docosahexanoic acid (4-HDoHE) and 7-hydroxy-
281 docosahexanoic acid (7-HDoHE). Both 4- and 7-HDoHE were detected in resting 
282 muscle at concentrations of 2.23 ng/g (Figure 5A) and 0.98 ng/g (Figure 5B) 
283 respectively. 7-HDoHE increased at 2 h post-exercise to 1.54 ng/g (P = 0.008) (Figure 
284 5B). Similarly, muscle 4-HDoHE tended to increase from pre-exercise levels at 2 h 
285 post-exercise (P = 0.069), and was statistically greater at 2 h compared than both 4 h 
286 (P = 0.011) and 24 h (P = 0.016) of recovery (Figure 5A). 
287 The 12-LOX enzyme converts the 22-carbon DHA to 14-hydroperxy-
288 docosahexanoic acid (14-HpDoHE) which can then be reduced to 14-HDoHE or 
289 metabolised to form the maresins (MaR 1 & 2) via the further action of 12-LOX. 
290 Similarly, the 15-LOX enzyme converts DHA to 17-hydroxy-docosahexanoic acid 
291 (17-HDoHE) which can be converted to the D-series resolvins via the subsequent 
292 action of 5-LOX. Therefore, 14-HDoHE and 17-HDoHE are pathway markers of 
293 increased MaR and RvD biosynthesis respectively. We detected 14-HDoHE in resting 
294 skeletal muscle at a concentration of 0.68 ng/g (Figure 5C). Muscle 14-HDoHE 
295 increased at 2 h post-exercise to concentrations of 1.60 ng/g (P = 0.005) (Figure 5C). 
296 In contrast, 17-HDoHE was not found to be present at detectable concentrations 
297 within human muscle biopsies at rest or at any time-point throughout exercise 
298 recovery (Supplemental Table 1). 
299 Multiple reaction monitoring (MRM) transitions corresponding to mature 
300 SPMs including the lipoxins (LXA4, LXB4, LXA5), E-series resolvins (RvE1 & 
301 RvE3), D-series resolvins (RvD1, RvD2, RvD5, RvD6), protectins (PD1 & 10S,17S-
302 DiHDoHE) and maresins (MaR1) were additionally monitored by our LC-MS/MS 
303 assay. Resting muscle tissue was found to contain low but detectable concentrations 
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304 of RvD6 (1.04 ng/g), PD1 (0.64 ng/g) and MaR1 (0.75 ng/g). The greatest average 
305 intramuscular concentrations of RvD6 (1.81 ng/g), PD1 (2.58 ng/g) and MaR1 (1.33 
306 ng/g) were observed at 2 h post-exercise. Despite this, the low and sporadic 
307 concentrations in certain subjects at particular time-points, combined with our 
308 repeated measures study design, precluded statistical analysis. Other mature SPMs 
309 including LXA4, LXB4, LXA5, RvD1, RvE3, RvD1, RvD2, RvD5 and the protectin 
310 D1 isomer 10S,17S-DiHDoHE were not found to be present at detectable levels 
311 locally within human muscle tissue biopsies at rest or throughout 24 h of post-
312 exercise recovery under the conditions used here (Supplemental Table 1).
313 Epoxygenase pathway: The cytochrome P-450 (CYP) enzymes metabolize n-
314 6 PUFA AA to a family of epoxyeicosatrienoic acid (EpETrE) regioisomers. Once 
315 formed, these bioactive EpETrEs are rapidly metabolized by the soluble epoxide 
316 hydrolase (sEH) enzyme to form corresponding downstream dihydroxyeicosatrienoic 
317 acids (DiHETrEs) vicinal diols. AA epoxides including 5,6-, 8,9-, 11,12- and 13,14-
318 EpETrE, were detected in resting muscle tissue at concentrations between 3-10 ng/g. 
319 Despite this, 5,6-EpETrE was the only primary enzymatic epoxy AA-metabolite that 
320 showed an effect for the exercise intervention, increasing 3-fold to 14.12 ng/g at 2 h 
321 post-exercise (P < 0.003) (Figure 6A). Downstream epoxide products of the sEH 
322 enzyme, 11,12-DiHETrE and 14,15-DiHETrE were present at much lower absolute 
323 concentrations in resting muscle (~1 ng/g), but increased in response to exercise with 
324 a peak response at 2 h of recovery (11,12-DiHETrE P = 0.026, 14,15-DiHETrE P = 
325 0.011) (Figure 6B & C). The 5,6-DiHETrE regioisomer was also detected at low 
326 levels in resting muscle, but was unchanged during post-exercise recovery 
327 (Supplemental Table 1). 
328 CYP epoxidase enzymes also have the capacity to metabolise the n-6 linoleic 
329 acid to bioactive lipid mediators including 9(10)-EpOME and 12(13)-EpOME and 
330 their downstream sEH products 9(10)-DiHOME and 12(13)-DiHOME. Both 9(10)- 
331 and 12(13)-EpOME were highly abundant in resting human muscle present at 
332 concentrations of 100.87 ng/g and 54.36 ng/g respectively, but were not influenced by 
333 the exercise intervention (Supplemental Table 1). In contrast, 9(10)- and 12(13)-
334 DiHOME were present at lower concentrations in resting muscle, but increased 
335 significantly at 2 h post-exercise (p=0.034 and p=0.020 respectively) (Figure 7). CYP 
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336 pathway metabolites of both AA and LA no longer differed from pre-exercise levels 
337 by 4- and 24-h of post-exercise recovery.
338
339
340
341
342
343
344 Discussion:
345 The present study explored the intramuscular lipid mediator response 
346 following an acute bout of resistance exercise. We identified 84 unique lipid 
347 mediators as present within skeletal muscle tissue. The early post-exercise response 
348 was characterized by increased tissue concentrations of a range of bioactive lipid 
349 derivatives of the cyclooxygenase (COX-1 & 2), lipoxygenase (5-, 12- & 15-LOX), 
350 and epoxygenase (CYP) pathways. Unexpectedly, however, peak induction of both 
351 pro-inflammatory and SPM pathway intermediates occurred simultaneously at 2 h of 
352 recovery. The findings from this study identify a complex parallel adaptive lipid 
353 response to resistance exercise that may play an essential role in regulating the onset 
354 and resolution of acute exercise-induced skeletal muscle inflammation. 
355 This is the first paper to use a targeted lipidomics approach to extensively 
356 characterize the lipid mediator profile of human skeletal muscle tissue at rest and in 
357 response to acute exercise. The majority of human research exploring the effect of 
358 exercise on lipid species has focused primarily on a select few prostaglandins, 
359 specifically PGE2 and PGF2ɑ, likely due to their complex role in regulating acute 
360 inflammation, perceptions of pain and purported roles in muscle cell 
361 growth/regeneration (13, 14, 53, 54). Although some studies have reported elevated 
362 circulating levels of PGE2 following exercise-induced muscle injury (5, 24, 50, 56), 
363 these findings have not yet been replicated in skeletal muscle tissue (29, 54). PGF2ɑ 
364 increases locally within skeletal muscle tissue following both eccentric (54) and 
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365 isotonic resistance exercise protocols (53). It plays a significant role in in-vitro 
366 myofibre hypertrophy (21) and post-exercise muscle protein synthesis (55). We 
367 previously found a significant increase in serum levels of the circulating PGF2ɑ 
368 metabolite 15-keto-PGF2ɑ early (1 h) following resistance exercise in humans (24). In 
369 the current study, PGE2 and PGF2ɑ were the most abundant AA derived PGs detected 
370 within muscle tissue and both transiently increased in abundance at 2 h following 
371 resistance exercise. Furthermore, intramuscular production of TXA2 (measured by 
372 heightened local TXB2 and 12(S)-HHTrE concentrations) increased at 2 h post-
373 exercise. This finding within the exercised musculature is consistent with prior reports 
374 of transiently increased systemic TXB2 concentrations following both acute maximal 
375 aerobic (16)  and resistance exercise (24). COX enzymes are also able to metabolize 
376 linoleic acid to form hydroxyoctadecadienoic acids (HODEs), which function 
377 stimulate the maturation of monocytes to form macrophages. Previous research has 
378 identified an increase in plasma in 9- and 13-HODE following 75km of cycling (27), 
379 however the present study is the first to detect an increase in 9- and 13- HODEs in 
380 skeletal muscle tissue following acute resistance exercise.       
381 Another major metabolic pathway leading to the formation of lipid species 
382 involved in the regulation of inflammation is the 5-lipoxygenase pathway. 5-LOX 
383 derived LTB4 is increased in human blood serum following acute resistance exercise 
384 (24) and high speed running (11). LTB4 is a potent neutrophil chemoattractant and a 
385 powerful stimulator of vasoconstriction and blood vessel permeability (26). 
386 Expression of 5-LOX is essentially limited to bone-marrow derived cells including 
387 inflammatory neutrophils and monocytes/macrophages (34). It is therefore not 
388 surprising that in the present study LTB4 was very lowly expressed in skeletal muscle 
389 tissue prior to exercise. At 2 h post-exercise, LTB4 was present at detectable 
390 concentrations in muscle biopsies from the majority of subjects, indicative of a 
391 potential increase from resting levels. Consistently, downstream derivatives of LTB4, 
392 including 12-Oxo LTB4 and 20-COOH LTB4, increased above resting levels at 2 h 
393 post-exercise. A less well-described branch of the 5-LOX pathway involves the 
394 metabolism of 22-carbon n-3 PUFA DHA to form mono-hydroxylated fatty acids 4- 
395 and 7-HDoHE. Both of these fatty acids were detected in resting skeletal muscle 
396 tissue and increased above basal levels at 2 h post-exercise. On the other hand, we 
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397 observed no change in 4- or 7-HDoHE during recovery from resistance exercise in 
398 human blood serum samples previously (24). 
399 In addition to 5-LOX, metabolites of the human platelet type 12-LOX enzyme 
400 12-HETE and its downstream derivate tetranor 12-HETE were also elevated within 
401 muscle post-exercise. Both metabolites are pro-inflammatory in nature and act 
402 transcellularly to modify the responsiveness of neutrophils to other chemotactic 
403 factors (31). We previously observed a similar increase in 12-HETE and downstream 
404 tetranor 12-HETE in human blood serum samples during recovery from resistance 
405 exercise (24). Interestingly 12-LOX expressing platelets are implicated in the 
406 transcellular biosynthesis of pro-resolution LX mediators through interactions with 5-
407 LOX expressing PMNs. This pathway involves leucocyte-platelet interactions during 
408 which the 5-LOX derived leukotriene intermediate LTA4 is taken up by 12-LOX 
409 expressing platelets for subsequent conversion to LXA4 (33, 48). Further, the 15-LOX 
410 pathway is implicated as a second endogenous route of LX biosynthesis species. 15-
411 LOX is highly expressed in alternatively activated macrophages and epithelial cells. 
412 The secretion of the 15-LOX product, 15-HETE, can be taken up by 5-LOX 
413 expressing cells and converted to LXA4 and LXB4 (37). In the current study we 
414 observed a trend towards an increase in 15-HETE 2 h post-exercise, which supports 
415 our prior observation in human blood serum samples (24). The simultaneous 
416 induction of the primary products of both the 5-LOX/12-LOX and 15-LOX/5-LOX 
417 pathways within skeletal muscle during post-exercise recovery is presumably a 
418 permissive environment for local LX biosynthesis. We were however, unable to 
419 detect LXA4 or LXB4 themselves within the muscle biopsy homogenates analysed 
420 here. Nevertheless, these local changes within the exercised musculature suggests that 
421 skeletal muscle tissue may potentially contribute to the previously reported systemic 
422 lipoxin response to resistance exercise following their release from exercised 
423 myofibers (24).
424 The CYP pathway is a third and less well-characterized branch of the AA 
425 metabolic pathway. The increase in epoxyeicosatrienoic acid regioisomer 5-6-EpETrE 
426 and dihydroxyeicosatrienoic acids 11,12- and 14,15-DiHETrE in skeletal muscle 
427 supports observations made in serum samples when measured during the early stages 
428 of post-exercise inflammation (24). The physiological function of these derivatives 
429 remains unexplored in skeletal muscle tissue. However, in vascular smooth muscle 
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430 and endothelium cells they play anti-inflammatory roles through in the inhibition of 
431 prostaglandin and cytokine induced inflammatory responses (49). CYP enzymes also 
432 metabolise linoleic acid via epoxidation to form epoxy-octadecanoic acids 
433 (EpOMEs). EpOMEs are rapidly hydrolysed by the sEH enzyme to form 
434 corresponding dihydroxy-octadecanoic acids (DiHOMEs) (15). EpOMEs and 
435 DiHOMEs are leukotoxins that play a role in the suppression of neutrophil respiratory 
436 burst activity, vasodilation and cellular apoptosis (28, 51). A cycling based 
437 intervention comprising of a 75km time trial had no effect on 9-10,DiHOME 1.5 h 
438 and 21 h post-exercise in plasma samples of competitive road cyclists (28). 
439 Alternatively, a bout of acute resistance exercise triggered an increase in 9(10)-
440 EpOME and 9-10,DiHOME in serum samples (24). Results from the present study 
441 showed an increase in 9,10-DiHOME and 12,13-DiHOME suggesting that 
442 discrepancies in the previous literature may be due to the differences in the type of 
443 exercise performed and the training status of the subjects.
444 Collectively, these findings demonstrate an increase in bioactive lipid derived 
445 mediators of the COX, LOX and CYP pathways during post-exercise muscle 
446 recovery. The concept of a biologically active inflammatory resolution programme 
447 governed by lipid derivatives was first proposed in a TNF-ɑ-stimulated model of 
448 acute inflammation in the murine air pouch (17). Within this model, early formation 
449 of LTB4 and PGE2 at the onset of inflammation was succeeded by a class-switching 
450 of eicosanoids to LXA4. During this process, interactions between inflammatory and 
451 host tissue cells enabled the biosynthesis of resolution mediators (17). Alternatively, 
452 in a model of zymosan-A stimulated murine peritonitis, the onset of inflammation was 
453 characterized by a concomitant increase in LTB4 and LXA4 followed by a late 
454 appearance of PGE2 at the onset of resolution (2). These findings demonstrate that the 
455 temporal regulation of lipids and their role in inflammation is likely cell-type and 
456 stimulus specific. Recent work from our group profiled the human lipid response to 
457 acute resistance exercise in serum samples (24). This study showed an increase in key 
458 prostaglandin, leukotriene, lipoxin and resolvin species during the early stages of 
459 acute inflammation (1-3 h), followed by an increase in 15-LOX derivatives and some 
460 prostaglandin metabolites (6-keto-PGF1ɑ and 13,14dh-15kPGE2) 24 h post- exercise 
461 (24). The present finding of increased intramuscular abundance of bioactive lipid 
462 mediators at 2 h post-exercise is overall consistent with findings from serum samples 
Au
th
or
 M
an
us
cr
ip
t
This article is protected by copyright. All rights reserved
463 (24), suggesting that muscle may be a major source of blood lipid mediators. 
464 Interestingly lipid species that require transcellular interactions, including lipoxins, 
465 resolvins and protectins, were either undetected, or very lowly expressed in skeletal 
466 muscle tissue, disproving the original hypothesis predicting a delayed increase in 
467 SPMs coincident with the resolution of acute inflammation. These lipids were 
468 detectable previously in human serum samples during post exercise recovery and play 
469 a vital role in the active resolution of acute inflammation (24). 
470 Conclusion:
471 This is the first study to characterize the lipid mediator profile of human 
472 skeletal muscle tissue at rest and following acute resistance exercise. We identified an 
473 increase in lipids autocoids derived from the COX, LOX and CYP pathways. Peak 
474 induction of AA derived classical pro-inflammatory prostaglandins (TXB2, PGE2 and 
475 PGF2ɑ) and leukotrienes (LTB4, 12-Oxo LTB4 and 20-COOH LTB4) occurred at 2 h 
476 post-exercise. Further various derivatives of the 5-LOX (5-HETE, 4-HDoHE and 7-
477 HDoHE), 12-LOX (12-HETE, tetranor 12-HETE and 14-HDoHE) and 15-LOX (15-
478 HETE) pathways were identified in abundance in skeletal muscle tissue at 2 h post-
479 exercise and may resemble transient cellular intermediates for the formation of pro-
480 resolution lipoxin and resolvin species. In alternative models of acute inflammation, 
481 these lipids are involved in coordinating a biologically active inflammatory resolution 
482 programme that is mechanistically linked to tissue healing. The present study was 
483 limited in that the analysis was performed during the first 24 hours of post-exercise 
484 recovery. Later time points may provide insight in to an ongoing cascade of complex 
485 lipidomic alterations (35, 39, 40). This study represents a descriptive analysis of the 
486 skeletal muscle lipid response to acute resistance exercise. Further mechanistic 
487 research exploring the physiological significance and function of these lipids, both 
488 locally within skeletal muscle tissue and following their systemic release, will be 
489 useful in further characterizing the significance of the intramuscular inflammatory 
490 response in post-exercise muscle recovery. 
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720
721
722
723 Figure Legends:
724
725 Figure 1: Metabolites of the cyclooxygenase (COX) pathway derived from 
726 arachidonic acid and eicosapentaenoic acid. Values depicted are mean values ± SEM. 
727 * denotes statistical significance compared to pre-exercise values (P < 0.05).
728 Figure 2: Metabolites of the 5-lipoxygenase (5-LOX) pathway derived from 
729 arachidonic acid. Values depicted are mean values ± SEM. * denotes statistical 
730 significance compared to pre-exercise values (P < 0.05).
731 Figure 3: Metabolites of the 12-lipoxygenase (12-LOX) pathway derived from 
732 arachidonic acid and eicosapentaenoic acid. Values depicted are mean values ± SEM. 
733 * denotes statistical significance compared to pre-exercise values (P < 0.05).
734 Figure 4: Metabolites of the 15-lipoxygenase (15-LOX) pathway derived from 
735 arachidonic acid and eicosapentaenoic acid. Values depicted are mean values ± SEM. 
736 * denotes statistical significance compared to pre-exercise values (P < 0.05). 
737 Figure 5: Metabolites of the lipoxygenase pathways derived from docosahexaenoic 
738 acid. Values depicted are mean values ± SEM. * denotes statistical significance 
739 compared to pre-exercise values (P < 0.05). ^ denotes statistical significance 
740 compared to 4 and 24 h post-exercise values (P < 0.05).   
741 Figure 6: Metabolites of the epoxygenase pathway derived from arachidonic acid. 
742 Values depicted are mean values ± SEM. * denotes statistical significance compared 
743 to pre-exercise values (P < 0.05).
744 Figure 7: Metabolites of the epoxygenase pathway derived from linoleic acid. Values 
745 depicted are mean values ± SEM. * denotes statistical significance compared to pre-
746 exercise values (P < 0.05).
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